Description
Fibrinolysis inhibiting factor is an immunomodulatory peptide with the sequence GPRP. This peptide induces acute immune hemolysis in hepatectomy models via thymic atrophy.
Fibrinolysis Inhibiting Factor
Product ID F3206
Cas No.
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Purity | ≥98% |
|---|---|
| Formula | C18H31N7O5 |
| Formula Wt. | 425.49 |
| IUPAC Name | (2S)-1-[(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxylic acid |
| Synonym | GPRP. |
| Solubility | Soluble in water. |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Nakatsuji T. Acceleration of thrombosis and hemolysis by fibrinolysis inhibiting factor and suppression by Ia antigen expressed on T cells in partially hepatectomized Lewis rats. Int J Hematol. 1996 Oct;64(3-4):181-8. PMID: 8923779.